China biopharma stocks fall after centralized tendering talks

Stocks of Chinese biopharma companies slid on Wednesday, possibly in response to a meeting Tuesday of China's National Medical Insurance

Read the full 204 word article

How to gain access

Continue reading with a
two-week free trial.